Sagimet Biosciences Inc. ( SGMT) - Key Metrics
SGMT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.26 | -$0.20 | -$0.20 |
| 2026Q1 | $0 | -$0.33 | -$0.26 | -$0.26 |
| 2025Q4 | $0 | -$0.29 | -$0.36 | -$0.36 |
| 2025Q3 | $0 | -$0.40 | -$0.31 | -$0.31 |
| 2025Q2 | $0 | -$0.32 | -$0.28 | -$0.28 |
SGMT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.43 |
| 2026Q1 | 0% | -3.96 |
| 2025Q4 | 0% | -5.10 |
| 2025Q3 | 0% | -4.29 |
| 2025Q2 | 0% | -5.95 |
SGMT
Price: $10.18
52 week price:
Earnings Per Share: -1.26 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 657.6 million